In the pharmaceutical sector, R&D process encompasses the period starting from the initiation of research until the granting of regulatory approval and product launch. In the pharmaceutical sector, R&D activities are the ones that bring the most added-value but with very high costs. In addition to being a high-cost process, drug development is a very long-term and a risky task. Centurion has created a well organized environment for research and development, with a self-consistent, a scientific and technical approaches that are contemporary, encouraging and responsive to the needs of society.
Research and Development department play a major role in consolidating and developing Centurion’s competitive position as one of Turkey’s leading generic pharmaceutical manufacturer’s. Our main target to be among leaders of the Turkish and European pharmaceutical market with care and quality strategy of Centurion with R&D activities which develop continuously through this aim. Centurion's R&D processes and technologies rely on a solid IP policy which constitutes a competitive advantage in the scenario of hospital generics and biosimilars.
We develop innovative generic medicines and biosmilars with value added, which are the product of our own in-house knowledge. Our capabilities provide us a broad range development options of liqid and lyophilized products as vial, PFS and cartrige forms.
Centurion R&D Department Focused on;
Conventional Parenteral and Nasal Generics
Centurion Research and Development Center consist of
Analytical development laboratories
R&D Biotech Laboratories and
Stability Chambers (Zone II and IV)
Research and Department Laboratories of Centurion has been equipped with more than 200 high-tech apparatus and equipments to develop and quality control tests for Hospital Generics and Biosimilar products.
Our R&D team profiles are contain Pharmaceutical Chemistry Experts, Pharmaceutical Technology Experts, Patent Agents, Pharmacologists, Analytical Chemists, Bioengineers. Our Research and Development team currently consists of 15 dedicated staff, who have scientific competence.
Research and Development department is resposible for;
Literature / Patent scanning and evaluation studies
Active substance / Excipiants assessment and analysis
Analytical method development
Laboratory and pilot scale productions
Analytical method validations
Clinical studies evaluations
Product improvement studies
Alternative source studies
New product stability studies (Zone II and Zone IV)
Preparation of Module 3 documents for authorization files in CTD format